Research letter: The impact of elexacaftor/tezacaftor/ivacaftor on adherence to nebulized maintenance therapies in people with cystic fibrosis

被引：7
|
作者：
Song, Jia Tong [1 ]
Desai, Sameer [2 ]
Franciosi, Alessandro N. [3 ,4 ]
Dagenais, Renee V. E. [5 ,6 ]
Quon, Bradley S.
机构：
[1] Univ British Columbia, Fac Med, Vancouver, BC, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[3] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada
[4] Univ British Columbia, Div Resp Med, Dept Med, Vancouver, BC, Canada
[5] St Paul s Hosp, Dept Pharm, Vancouver, BC, Canada
[6] St Pauls Hosp, Adult Cyst Fibrosis Program, Vancouver, BC, Canada
来源：
JOURNAL OF CYSTIC FIBROSIS | 2022年 / 21卷 / 06期
关键词：
D O I：
10.1016/j.jcf.2022.05.005
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：1080 / 1081
页数：2
相关论文
共 50 条
  • [1] ADHERENCE TO NEBULISED THERAPIES IN PEOPLE WITH CYSTIC FIBROSIS STARTING ELEXACAFTOR/TEZACAFTOR/IVACAFTOR (KAFTRIO)
    Howell, I. B.
    Tugwell, A.
    Bhaskaran, D.
    Bell, N. J.
    [J]. THORAX, 2021, 76 : A40 - A40
  • [2] Impact of elexacaftor/tezacaftor/ivacaftor on bacterial cultures from people with cystic fibrosis
    Beck, Michael R.
    Hornick, Douglas B.
    Pena, Tahuanty A.
    Singh, Sachinkumar B.
    Wright, Brittany A.
    [J]. PEDIATRIC PULMONOLOGY, 2023, 58 (05) : 1569 - 1573
  • [3] Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis
    Nichols, David P.
    Paynter, Alex C.
    Heltshe, Sonya L.
    Donaldson, Scott H.
    Frederick, Carla A.
    Freedman, Steven D.
    Gelfond, Daniel
    Hoffman, Lucas R.
    Kelly, Andrea
    Narkewicz, Michael R.
    Pittman, Jessica E.
    Ratjen, Felix
    Rosenfeld, Margaret
    Sagel, Scott D.
    Schwarzenberg, Sarah Jane
    Singh, Pradeep K.
    Solomon, George M.
    Stalvey, Michael S.
    Clancy, John P.
    Kirby, Shannon
    Van Dalfsen, Jill M.
    Kloster, Margaret H.
    Rowe, Steven M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (05) : 529 - 539
  • [4] Elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations
    Fainardi, Valentina
    Cresta, Federico
    Sorio, Claudio
    Melotti, Paola
    Pesce, Emanuela
    Deolmi, Michela
    Longo, Francesco
    Karina, Kleinfelder
    Esposito, Susanna
    Pisi, Giovanna
    [J]. PEDIATRIC PULMONOLOGY, 2024,
  • [5] Use of Chronic Maintenance Therapies for Cystic Fibrosis in Patients on Elexacaftor, Tezacaftor, and Ivacaftor at a Single Center
    Toporek, A.
    Merlo, C. A.
    West, N. E.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [6] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [7] Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1589): : 5 - 7
  • [8] Impact of elexacaftor/tezacaftor/ivacaftor on depression and anxiety in cystic fibrosis
    Zhang, Lijia
    Albon, Dana
    Jones, Marieke
    Bruschwein, Heather
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [9] The impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis
    Hergenroeder, Georgene E.
    Faino, Anna
    Bridges, Gracia
    Bartlett, Lauren E.
    Cogen, Jonathan
    Green, Nicole
    Mcnamara, Sharon
    Nichols, David P.
    Ramos, Kathleen J.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (06) : 1048 - 1053
  • [10] Cystic Fibrosis: Triple Therapy with Elexacaftor, Tezacaftor and Ivacaftor
    Lorenz, Judith
    [J]. PNEUMOLOGIE, 2022, 76 (03): : 153 - 153
12345